|
JPS552601A
(en)
|
1978-06-20 |
1980-01-10 |
Yamasa Shoyu Co Ltd |
Anti-tumor agent for non-injection use
|
|
US5674998A
(en)
|
1989-09-15 |
1997-10-07 |
Gensia Inc. |
C-4' modified adenosine kinase inhibitors
|
|
US6110901A
(en)
*
|
1990-07-03 |
2000-08-29 |
American Cyanamid Company |
Method for treating RNA viral infections by using RNA chain terminators
|
|
US5432272A
(en)
|
1990-10-09 |
1995-07-11 |
Benner; Steven A. |
Method for incorporating into a DNA or RNA oligonucleotide using nucleotides bearing heterocyclic bases
|
|
JPH07242544A
(ja)
|
1994-03-01 |
1995-09-19 |
Takeda Chem Ind Ltd |
抗腫瘍剤
|
|
PT879056E
(pt)
|
1996-01-23 |
2002-10-31 |
Ribapharm Inc |
Modulacao da expressao das citocinas th1/th2 atraves de ribavirina em linfocitos t activados
|
|
DE69729887T2
(de)
|
1996-10-16 |
2005-07-28 |
ICN Pharmaceuticals, Inc., Costa Mesa |
Purin-L-Nukleoside, Analoga und deren Verwendung
|
|
AU738170B2
(en)
|
1996-10-16 |
2001-09-13 |
Icn Pharmaceuticals, Inc. |
Monocyclic L-nucleosides, analogs and uses thereof
|
|
US20030064945A1
(en)
|
1997-01-31 |
2003-04-03 |
Saghir Akhtar |
Enzymatic nucleic acid treatment of diseases or conditions related to levels of epidermal growth factor receptors
|
|
WO1999061583A2
(en)
|
1998-05-28 |
1999-12-02 |
Incara Pharmaceuticals Corp. |
Carbohydrate-based scaffold compounds, combinatorial libraries and methods for their construction
|
|
DE19855963A1
(de)
|
1998-12-04 |
2000-06-08 |
Herbert Schott |
Amphiphile Glycerylnucleotide, Verfahren zu ihrer Herstellung und ihre Verwendung
|
|
WO2000069877A1
(en)
|
1999-05-12 |
2000-11-23 |
Yamasa Corporation |
4'-c-ethynyl purine nucleosides
|
|
US6495677B1
(en)
|
2000-02-15 |
2002-12-17 |
Kanda S. Ramasamy |
Nucleoside compounds
|
|
US6815542B2
(en)
|
2000-06-16 |
2004-11-09 |
Ribapharm, Inc. |
Nucleoside compounds and uses thereof
|
|
UA72612C2
(en)
|
2000-07-06 |
2005-03-15 |
|
Pyrido[2.3-d]pyrimidine and pyrimido[4.5-d]pyrimidine nucleoside analogues, prodrugs and method for inhibiting growth of neoplastic cells
|
|
US7105499B2
(en)
|
2001-01-22 |
2006-09-12 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
|
SI1355916T1
(sl)
*
|
2001-01-22 |
2007-04-30 |
Merck & Co Inc |
Nukleozidni derivati kot inhibitorji RNA-odvisne RNA virusne polimeraze
|
|
US20030124513A1
(en)
|
2001-05-29 |
2003-07-03 |
Mcswiggen James |
Enzymatic nucleic acid treatment of diseases or conditions related to levels of HIV
|
|
WO2003070912A2
(en)
|
2001-06-06 |
2003-08-28 |
Sirna Therapeutics, Inc. |
RNA INTERFERENCE MEDIATED INHIBITION OF EPIDERMAL GROWTH FACTOR RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
|
US20030175950A1
(en)
|
2001-05-29 |
2003-09-18 |
Mcswiggen James A. |
RNA interference mediated inhibition of HIV gene expression using short interfering RNA
|
|
GB0114286D0
(en)
|
2001-06-12 |
2001-08-01 |
Hoffmann La Roche |
Nucleoside Derivatives
|
|
US6962991B2
(en)
|
2001-09-12 |
2005-11-08 |
Epoch Biosciences, Inc. |
Process for the synthesis of pyrazolopyrimidines
|
|
AU2002330154A1
(en)
|
2001-09-28 |
2003-04-07 |
Centre National De La Recherche Scientifique |
Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides
|
|
EP1438054A4
(en)
*
|
2001-09-28 |
2006-07-26 |
Idenix Cayman Ltd |
METHODS AND COMPOSITIONS FOR TREATING FLAVIVIRUS AND PESTIVIRUS USING MODIFIED NUCLEOSIDE AT 4 'POSITION
|
|
AU2002351077A1
(en)
|
2001-11-05 |
2003-05-19 |
Exiqon A/S |
Oligonucleotides modified with novel alpha-l-rna analogues
|
|
US7125982B1
(en)
|
2001-12-05 |
2006-10-24 |
Frayne Consultants |
Microbial production of nuclease resistant DNA, RNA, and oligo mixtures
|
|
EP1572705A2
(en)
|
2002-01-17 |
2005-09-14 |
Ribapharm, Inc. |
Sugar modified nucleosides as viral replication inhibitors
|
|
WO2003062256A1
(en)
|
2002-01-17 |
2003-07-31 |
Ribapharm Inc. |
2'-beta-modified-6-substituted adenosine analogs and their use as antiviral agents
|
|
WO2003068244A1
(en)
|
2002-02-13 |
2003-08-21 |
Merck & Co., Inc. |
Methods of inhibiting orthopoxvirus replication with nucleoside compounds
|
|
WO2003073989A2
(en)
|
2002-02-28 |
2003-09-12 |
Biota, Inc. |
Nucleoside 5'-monophosphate mimics and their prodrugs
|
|
AU2003241621A1
(en)
|
2002-05-24 |
2003-12-12 |
Isis Pharmaceuticals, Inc. |
Oligonucleotides having modified nucleoside units
|
|
WO2003099840A1
(en)
|
2002-05-24 |
2003-12-04 |
Isis Pharmaceuticals, Inc. |
Oligonucleotides having modified nucleoside units
|
|
JP2005530843A
(ja)
|
2002-06-21 |
2005-10-13 |
メルク エンド カムパニー インコーポレーテッド |
Ｒｎａ依存性ｒｎａウィルスポリメラーゼ阻害剤としてのヌクレオシド誘導体
|
|
AU2003269892A1
(en)
|
2002-06-27 |
2004-01-19 |
Isis Pharmaceuticals, Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
|
EP1525209B1
(en)
|
2002-06-28 |
2017-11-15 |
Idenix Pharmaceuticals LLC |
1'-, 2'- and 3' -modified nucleoside derivatives for treating flaviviridae infections
|
|
PT1523489E
(pt)
*
|
2002-06-28 |
2014-06-24 |
Centre Nat Rech Scient |
Profármacos de nucleósido modificado em 2' e 3' para tratamento de infecções por flaviridae
|
|
AU2003269902A1
(en)
|
2002-07-16 |
2004-02-02 |
Isis Pharmaceuticals, Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
|
WO2004014312A2
(en)
|
2002-08-08 |
2004-02-19 |
Sirna Therapeutics, Inc. |
Small-mer compositions and methods of use
|
|
WO2004037159A2
(en)
|
2002-10-23 |
2004-05-06 |
Obetherapy Biotechnology |
Compounds, compositions and methods for modulating fat metabolism
|
|
US20040229840A1
(en)
*
|
2002-10-29 |
2004-11-18 |
Balkrishen Bhat |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
|
US7393954B2
(en)
|
2002-12-12 |
2008-07-01 |
Reliable Biopharmaceutical Corporation |
Process for the production of pentostatin aglycone and pentostatin
|
|
AU2003225705A1
(en)
|
2003-03-07 |
2004-09-30 |
Ribapharm Inc. |
Cytidine analogs and methods of use
|
|
EP1613261A4
(en)
|
2003-04-09 |
2011-01-26 |
Novo Nordisk As |
INTRA-CELLULAR FORMATION OF PEPTIDE CONJUGATES
|
|
US20040259934A1
(en)
|
2003-05-01 |
2004-12-23 |
Olsen David B. |
Inhibiting Coronaviridae viral replication and treating Coronaviridae viral infection with nucleoside compounds
|
|
EP1656093A2
(en)
|
2003-05-14 |
2006-05-17 |
Idenix (Cayman) Limited |
Nucleosides for treatment of infection by corona viruses, toga viruses and picorna viruses
|
|
US20040229839A1
(en)
|
2003-05-14 |
2004-11-18 |
Biocryst Pharmaceuticals, Inc. |
Substituted nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
|
|
WO2005020885A2
(en)
|
2003-05-21 |
2005-03-10 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for the treatment of severe acute respiratory syndrome (sars)
|
|
WO2004106356A1
(en)
|
2003-05-27 |
2004-12-09 |
Syddansk Universitet |
Functionalized nucleotide derivatives
|
|
BRPI0419345B8
(pt)
|
2003-05-30 |
2021-05-25 |
Gilead Pharmasset Llc |
uso do (2r)-2-desoxi-2-flúor-2-c-metil nucleosídeo e de uma composição farmacêutica que o compreende
|
|
EP1644479A4
(en)
|
2003-06-16 |
2008-04-23 |
Mark W Grinstaff |
FUNCTIONAL SYNTHETIC MOLECULES AND MACROMOLECULES FOR GENERAL FEEDING
|
|
DK1658302T3
(da)
*
|
2003-07-25 |
2010-11-22 |
Idenix Pharmaceuticals Inc |
Purinnukleosidanaloge til behandling af sygdomme forårsaget af Flavirividae, herunder hepatitis C
|
|
KR20060123707A
(ko)
|
2003-08-27 |
2006-12-04 |
바이오타, 인코포레이티드 |
치료제로서의 신규 트리시클릭 뉴클레오시드 또는뉴클레오티드
|
|
WO2006000922A2
(en)
|
2004-06-23 |
2006-01-05 |
Idenix (Cayman) Limited |
5-aza-7-deazapurine derivatives for treating infections with flaviviridae
|
|
JP2008508319A
(ja)
|
2004-07-29 |
2008-03-21 |
メタバシス・セラピューティクス・インコーポレイテッド |
新規ヌクレオシド誘導体
|
|
EP1828217A2
(en)
|
2004-12-16 |
2007-09-05 |
Febit Biotech GmbH |
Polymerase-independent analysis of the sequence of polynucleotides
|
|
US7524831B2
(en)
*
|
2005-03-02 |
2009-04-28 |
Schering Corporation |
Treatments for Flaviviridae virus infection
|
|
EP1858889A1
(en)
|
2005-03-08 |
2007-11-28 |
Biota Scientific Management Pty. Ltd. |
Bicyclic nucleosides and nucleotides as therapeutic agents
|
|
WO2007144686A1
(en)
|
2005-03-09 |
2007-12-21 |
Idenix (Cayman) Limited |
Nucleosides with non-natural bases as anti-viral agents
|
|
EP1877054A2
(en)
|
2005-03-30 |
2008-01-16 |
Sirtris Pharmaceuticals, Inc. |
Nicotinamide riboside and analogues thereof
|
|
EP1876894A1
(en)
|
2005-04-26 |
2008-01-16 |
The Board of Trustees of the University of Illinois |
Nucleoside compounds and methods of use thereof
|
|
WO2007020018A1
(en)
|
2005-08-12 |
2007-02-22 |
Universite Libre De Bruxelles |
Use of purinergic and pyrimidinergic receptor agonists for dendritic cells based immunotherapies
|
|
JP2009504704A
(ja)
|
2005-08-15 |
2009-02-05 |
エフ．ホフマン−ラ ロシュ アーゲー |
抗ウイルス４′−置換プロヌクレオチドホスホルアミダート
|
|
NZ567272A
(en)
|
2005-09-26 |
2012-02-24 |
Pharmasset Inc |
Modified 4'-nucleosides as antiviral agents
|
|
EP2010553A1
(en)
|
2006-04-03 |
2009-01-07 |
AstraZeneca AB |
Substituted adenines and the uses thereof
|
|
GB0614947D0
(en)
|
2006-07-27 |
2006-09-06 |
Isis Innovation |
Epitope reduction therapy
|
|
US7951789B2
(en)
|
2006-12-28 |
2011-05-31 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
|
US8071568B2
(en)
|
2007-01-05 |
2011-12-06 |
Merck Sharp & Dohme Corp. |
Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infection
|
|
SI2114980T1
(sl)
|
2007-01-12 |
2012-11-30 |
Biocryst Pharm Inc |
Protivirusni nukleozidni analogi
|
|
US20120135091A1
(en)
|
2007-01-18 |
2012-05-31 |
Roth Mark B |
Methods and compositions for enhancing lifespan involving sirtuin-modulating compounds and chalcogenides
|
|
KR20100014878A
(ko)
|
2007-01-31 |
2010-02-11 |
앨리오스 바이오파마 인크. |
2-5ａ 유도체, 및 항암제, 항바이러스제 및 항기생충제로서 이의 용도
|
|
JP2008214305A
(ja)
|
2007-03-07 |
2008-09-18 |
Kotobuki Seiyaku Kk |
置換アミン誘導体及びこれを有効成分とする医薬組成物
|
|
CN101765369A
(zh)
|
2007-03-19 |
2010-06-30 |
俄勒冈州由俄勒冈州立大学代表州高等教育委员会行使 |
曼尼希碱n-氧化物药物
|
|
WO2008117047A1
(en)
|
2007-03-27 |
2008-10-02 |
Astrazeneca Ab |
Pyrazolo[3, 4-d]pyrimidine derivatives as antibacterial compounds
|
|
US7964580B2
(en)
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
|
US20080255038A1
(en)
|
2007-04-11 |
2008-10-16 |
Samuel Earl Hopkins |
Pharmaceutical compositions
|
|
EP1980568A1
(de)
|
2007-04-13 |
2008-10-15 |
Eberhard Karls Universität Tübingen |
Ethinylierte Heterodinucleosidphosphatanaloga, Verfahren zu deren Herstellung und deren Verwendung
|
|
PL2014771T3
(pl)
|
2007-06-25 |
2015-05-29 |
Anadys Pharmaceuticals Inc |
Ciągły proces hydrolizy enzymatycznej
|
|
GB0712494D0
(en)
|
2007-06-27 |
2007-08-08 |
Isis Innovation |
Substrate reduction therapy
|
|
GB0718575D0
(en)
|
2007-09-24 |
2007-10-31 |
Angeletti P Ist Richerche Bio |
Nucleoside derivatives as inhibitors of viral polymerases
|
|
US20090318380A1
(en)
|
2007-11-20 |
2009-12-24 |
Pharmasset, Inc. |
2',4'-substituted nucleosides as antiviral agents
|
|
AU2008333339A1
(en)
|
2007-12-07 |
2009-06-11 |
F. Hoffmann-La Roche Ag |
HCV NS3 protease replicon shuttle vectors
|
|
US20090176732A1
(en)
|
2007-12-21 |
2009-07-09 |
Alios Biopharma Inc. |
Protected nucleotide analogs
|
|
US20090181921A1
(en)
|
2007-12-21 |
2009-07-16 |
Alios Biopharma Inc. |
2-5a analogs and their methods of use
|
|
ATE551342T1
(de)
|
2008-02-22 |
2012-04-15 |
Irm Llc |
Heterocyclische verbindungen und zusammensetzungen als c-kit- und pdgfr- kinasehemmer
|
|
DK2262807T3
(en)
|
2008-03-19 |
2015-11-30 |
Chembridge Corp |
NOVEL tyrosine kinase inhibitors
|
|
WO2009129120A2
(en)
|
2008-04-15 |
2009-10-22 |
Rfs Pharma, Llc |
Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections
|
|
WO2010036407A2
(en)
|
2008-05-15 |
2010-04-01 |
Biocryst Pharmaceuticals, Inc. |
Antiviral nucleoside analogs
|
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
|
AR072906A1
(es)
|
2008-08-06 |
2010-09-29 |
Novartis Ag |
Nucleosidos modificados utiles como antivirales
|
|
GB0815968D0
(en)
|
2008-09-03 |
2008-10-08 |
Angeletti P Ist Richerche Bio |
Antiviral agents
|
|
US20110171192A1
(en)
|
2008-09-05 |
2011-07-14 |
Hiroshi Tomiyama |
Substituted amine derivative and medicinal composition comprising same as the active ingredient
|
|
WO2010030858A1
(en)
|
2008-09-15 |
2010-03-18 |
Enanta Pharmaceuticals, Inc. |
4'-allene-substituted nucleoside derivatives
|
|
US20100099079A1
(en)
|
2008-09-26 |
2010-04-22 |
Uprichard Susan L |
Non-dividing cell-based assay for high throughput antiviral compound screening
|
|
CL2009002206A1
(es)
*
|
2008-12-23 |
2011-08-26 |
Gilead Pharmasset Llc |
Compuestos derivados de pirrolo -(2-3-d]-pirimidin-7(6h)-tetrahidrofuran-2-il fosfonamidato, composicion farmaceutica; y su uso en el tratamiento de enfermedades virales.
|
|
WO2010088924A1
(en)
|
2009-02-06 |
2010-08-12 |
Telormedix Sa |
Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
|
|
EP2393815A4
(en)
|
2009-02-06 |
2012-11-21 |
Rfs Pharma Llc |
PURIN NUCLEOSIDE MONOPHOSPHATE PRODRUGS FOR THE TREATMENT OF CANCER AND VIRUS INFECTIONS
|
|
AU2010226466A1
(en)
|
2009-03-20 |
2011-10-20 |
Alios Biopharma, Inc. |
Substituted nucleoside and nucleotide analogs
|
|
US20100240604A1
(en)
|
2009-03-20 |
2010-09-23 |
Alios Biopharma, Inc. |
Protected nucleotide analogs
|
|
JP5364159B2
(ja)
|
2009-05-08 |
2013-12-11 |
アステラス製薬株式会社 |
ジアミノへテロ環カルボキサミド化合物
|
|
EP2264169A1
(en)
|
2009-06-15 |
2010-12-22 |
Qiagen GmbH |
Modified siNA
|
|
US20100331397A1
(en)
|
2009-06-24 |
2010-12-30 |
Alios Biopharma, Inc. |
2-5a analogs and their methods of use
|
|
WO2011005860A2
(en)
|
2009-07-07 |
2011-01-13 |
Alnylam Pharmaceuticals, Inc. |
5' phosphate mimics
|
|
US20150018301A1
(en)
|
2009-11-06 |
2015-01-15 |
The Johns Hopkins University |
LRRK-2-Mediated Neuronal Toxicity
|
|
WO2011133871A2
(en)
|
2010-04-22 |
2011-10-27 |
Alnylam Pharmaceuticals, Inc. |
5'-end derivatives
|
|
EA025311B1
(ru)
|
2010-07-19 |
2016-12-30 |
Гайлид Сайэнсиз, Инк. |
Способы получения диастереомерно чистых фосфорамидатных пролекарств
|
|
EP2619215B1
(en)
|
2010-09-22 |
2018-09-05 |
Alios Biopharma, Inc. |
Azido nucleosides and nucleotide analogs
|
|
WO2012040126A1
(en)
|
2010-09-22 |
2012-03-29 |
Alios Biopharma, Inc. |
Substituted nucleotide analogs
|
|
GEP20156313B
(en)
|
2010-09-22 |
2015-07-10 |
Alios Biopharma Inc |
Substituted nucleotide analogs
|
|
WO2012041965A1
(en)
|
2010-09-29 |
2012-04-05 |
Universidad Nacional De Quilmes |
Process for producing dialkylphosphotriesters of nucleosides by enzymatic transesterification and deprotection thereof for producing nucleoside monophosphates
|
|
CN102516339B
(zh)
|
2010-10-21 |
2014-03-19 |
四川大学华西医院 |
嘧啶并嘧啶化合物及其核苷类似衍生物和制备方法及用途
|
|
WO2012074547A2
(en)
|
2010-11-29 |
2012-06-07 |
New York University |
STEROID COMPOUNDS AS RORγt MODULATORS AND USES THEREOF
|
|
EP2655392B1
(en)
|
2010-12-22 |
2018-04-18 |
Alios Biopharma, Inc. |
Cyclic nucleotide analogs
|
|
CN103403014B
(zh)
|
2011-01-03 |
2016-07-06 |
河南美泰宝生物制药有限公司 |
O-(经取代的苯甲基)氨基磷酸酯化合物及其治疗用途
|
|
ES2744587T3
(es)
|
2011-04-13 |
2020-02-25 |
Gilead Sciences Inc |
Análogos de N-nucleósido de pirimidina 1-sustituidos para un tratamiento antiviral
|
|
EP2696681B1
(en)
|
2011-04-13 |
2018-10-03 |
Merck Sharp & Dohme Corp. |
2'-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
|
CA2843885C
(en)
|
2011-08-01 |
2020-03-10 |
Mbc Pharma, Inc. |
Vitamin b6 derivatives of nucleotides, acyclonucleotides and acyclonucleoside phosphonates
|
|
CN102408411B
(zh)
|
2011-09-19 |
2014-10-22 |
北京康辰药业股份有限公司 |
一种含喹啉基的羟肟酸类化合物及其制备方法、以及含有该化合物的药物组合物及其应用
|
|
US8575119B2
(en)
|
2011-09-23 |
2013-11-05 |
Enanta Pharmaceuticals, Inc. |
2′-chloroacetylenyl substituted nucleoside derivatives
|
|
UA111761C2
(uk)
|
2011-12-20 |
2016-06-10 |
Рібосаєнс Ллс |
2',4'-дифтор-2'-метилзаміщені нуклеозидні похідні як інгібітори реплікації phk вірусу гепатиту c
|
|
SG10201610936RA
(en)
|
2011-12-22 |
2017-02-27 |
Alios Biopharma Inc |
Substituted nucleosides, nucleotides and analogs thereof
|
|
US8980865B2
(en)
|
2011-12-22 |
2015-03-17 |
Alios Biopharma, Inc. |
Substituted nucleotide analogs
|
|
US9441007B2
(en)
|
2012-03-21 |
2016-09-13 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
|
HK1203513A1
(en)
|
2012-03-21 |
2015-10-30 |
艾丽奥斯生物制药有限公司 |
Methods of preparing substituted nucleotide analogs
|
|
WO2013142159A1
(en)
*
|
2012-03-21 |
2013-09-26 |
Alios Biopharma, Inc. |
Pharmaceutical combinations comprising a thionucleotide analog
|
|
US8916538B2
(en)
|
2012-03-21 |
2014-12-23 |
Vertex Pharmaceuticals Incorporated |
Solid forms of a thiophosphoramidate nucleotide prodrug
|
|
RS58437B1
(sr)
*
|
2012-03-21 |
2019-04-30 |
Alios Biopharma Inc |
Supstituisani nukleozidi, nukleotidi i njihovi analozi
|
|
EP2827876A4
(en)
|
2012-03-22 |
2015-10-28 |
Alios Biopharma Inc |
PHARMACEUTICAL COMBINATIONS WITH A THIONUCLEOTIDE ANALOG
|
|
CN102816197B
(zh)
|
2012-08-24 |
2015-04-29 |
四川大学华西医院 |
一种新的嘧啶并嘧啶类核苷类似物、制备方法及其形成的超分子结构和应用
|
|
MX2015005500A
(es)
|
2012-10-29 |
2016-02-09 |
Cocrystal Pharma Inc |
Nucleotidos de pirimidina y sus profarmacos de monofosfato para el tratamiento de infecciones virales y cancer.
|
|
EP2935304A1
(en)
*
|
2012-12-19 |
2015-10-28 |
IDENIX Pharmaceuticals, Inc. |
4'-fluoro nucleosides for the treatment of hcv
|
|
US9598457B2
(en)
|
2012-12-21 |
2017-03-21 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
|
GEP201706757B
(en)
|
2012-12-21 |
2017-10-25 |
Alios Biopharma Inc |
Substituted nucleosides, nucleotides and analogs thereof
|
|
TW201526899A
(zh)
|
2013-02-28 |
2015-07-16 |
Alios Biopharma Inc |
醫藥組成物
|
|
WO2014164533A1
(en)
|
2013-03-11 |
2014-10-09 |
Vertex Pharmaceuticals Incorporated |
Methods of stereoselective synthesis of substituted nucleoside analogs
|
|
AU2014248116A1
(en)
|
2013-04-05 |
2015-11-12 |
Alios Biopharma, Inc. |
Hepatitis C viral infection treatment using a combination of compounds
|
|
MA46490A1
(fr)
|
2013-05-16 |
2021-04-30 |
Riboscience Llc |
Dérivés de nucléosides 4'- fluoro-2' - méthyle substitués
|
|
EP3424938B1
(en)
|
2013-06-26 |
2020-07-22 |
Janssen BioPharma, Inc. |
4'-azidoalkyl-substituted nucleosides, nucleotides and analogs thereof
|
|
HK1224229A1
(zh)
|
2013-06-26 |
2017-08-18 |
Alios Biopharma, Inc. |
取代的核苷，核苷酸及其类似物
|
|
JP6562908B2
(ja)
|
2013-10-11 |
2019-08-21 |
ヤンセン バイオファーマ インク． |
置換ヌクレオシド、置換ヌクレオチドおよびその類似体
|
|
TN2016000566A1
(en)
|
2014-06-24 |
2018-04-04 |
Alios Biopharma Inc |
Substituted nucleosides, nucleotides and analogs thereof
|
|
HUE051986T2
(hu)
|
2014-06-24 |
2021-04-28 |
Janssen Biopharma Inc |
Helyettesített nukleozidok, nukleotidek és analógjaik virális fertõzés kezelésére való alkalmazásra
|
|
BR112016029994A2
(pt)
|
2014-06-24 |
2017-08-22 |
Alios Biopharma Inc |
métodos de preparação de análogos de nucleotídeo substituídos
|
|
JP2017525681A
(ja)
|
2014-07-22 |
2017-09-07 |
アリオス バイオファーマ インク． |
パラミクソウイルスの治療方法
|
|
JP2017523988A
(ja)
|
2014-08-05 |
2017-08-24 |
アリオス バイオファーマ インク． |
パラミクソウイルスを治療するための併用療法
|
|
HK1243714A1
(zh)
|
2014-10-28 |
2018-07-20 |
Alios Biopharma, Inc. |
制备取代的核苷类似物的方法
|
|
MA41441A
(fr)
|
2014-12-19 |
2017-12-12 |
Alios Biopharma Inc |
Nucléosides substitués, nucléotides et analogues de ceux-ci
|
|
MA41213A
(fr)
|
2014-12-19 |
2017-10-24 |
Alios Biopharma Inc |
Nucléosides substitués, nucléotides et analogues de ceux-ci
|
|
US20190169221A1
(en)
|
2016-08-12 |
2019-06-06 |
Janssen Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
|
WO2018081449A1
(en)
|
2016-10-27 |
2018-05-03 |
Alios Biopharma, Inc. |
Methods for treating respiratory syncytial virus infection
|